BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 34399104)

  • 1. "The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain".
    Escrivá BF; Mochón MDO; González RM; García CS; Pla AT; Ricart AS; García MM; Aranda IT; García FG; Cardona CG
    J Clin Virol; 2021 Oct; 143():104941. PubMed ID: 34399104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Abbott Panbio™ COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care.
    Eikelenboom-Boskamp A; den Ouden M; de Groot T; Stobernack T; Wertheim H; Voss A
    PLoS One; 2023; 18(2):e0276244. PubMed ID: 36827362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
    Torres I; Poujois S; Albert E; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Apr; 27(4):636.e1-636.e4. PubMed ID: 33421573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
    Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population.
    Gallardo-Alfaro L; Lorente-Montalvo P; Cañellas M; Carandell E; Oliver A; Rojo E; Riera B; Llobera J; Bulilete O;
    BMC Pediatr; 2023 Aug; 23(1):433. PubMed ID: 37644389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Panbio™ COVID-19 ag rapid test at an emergency room in a hospital in São Paulo, Brazil.
    Faíco-Filho KS; Júnior FEF; Moreira LVL; Lins PRG; Justo AFO; Bellei N
    Braz J Infect Dis; 2022; 26(2):102349. PubMed ID: 35358471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
    Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
    J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak.
    McKay SL; Tobolowsky FA; Moritz ED; Hatfield KM; Bhatnagar A; LaVoie SP; Jackson DA; Lecy KD; Bryant-Genevier J; Campbell D; Freeman B; Gilbert SE; Folster JM; Medrzycki M; Shewmaker PL; Bankamp B; Radford KW; Anderson R; Bowen MD; Negley J; Reddy SC; Jernigan JA; Brown AC; McDonald LC; Kutty PK;
    Ann Intern Med; 2021 Jul; 174(7):945-951. PubMed ID: 33900791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Mboumba Bouassa RS; Veyer D; Péré H; Bélec L
    Int J Infect Dis; 2021 May; 106():8-12. PubMed ID: 33746093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda.
    Bwogi J; Lutalo T; Tushabe P; Bukenya H; Eliku JP; Ssewanyana I; Nabadda S; Nsereko C; Cotten M; Downing R; Lutwama J; Kaleebu P; ;
    PLoS One; 2022; 17(5):e0265334. PubMed ID: 35536792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection.
    Gremmels H; Winkel BMF; Schuurman R; Rosingh A; Rigter NAM; Rodriguez O; Ubijaan J; Wensing AMJ; Bonten MJM; Hofstra LM
    EClinicalMedicine; 2021 Jan; 31():100677. PubMed ID: 33521610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy Of Panbio
    Asif S; Ahmed A; Gul A; Abbasi T
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S928-S931. PubMed ID: 36550646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating diagnostic accuracies of Panbio™ test and RT-PCR for the detection of SARS-CoV-2 in Addis Ababa, Ethiopia using Bayesian Latent-Class Models (BLCM).
    Sisay A; Hartnack S; Tiruneh A; Desalegn Y; Tesfaye A; Desta AF
    PLoS One; 2022; 17(10):e0268160. PubMed ID: 36260547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.
    Ngo Nsoga MT; Kronig I; Perez Rodriguez FJ; Sattonnet-Roche P; Da Silva D; Helbling J; Sacks JA; de Vos M; Boehm E; Gayet-Ageron A; Berger A; Jacquerioz-Bausch F; Chappuis F; Kaiser L; Schibler M; Renzoni A; Eckerle I
    PLoS One; 2021; 16(6):e0253321. PubMed ID: 34166410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection.
    Oh SM; Lee JS; Jo HJ; Kim D; Park D; Hwang YH; Choi Y; Lee CM; Lee S; Chang E; Lee E; Kim TS; Seong MW; Choe PG; Kim NJ
    BMC Res Notes; 2022 Dec; 15(1):357. PubMed ID: 36471453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan.
    Takeuchi Y; Akashi Y; Kato D; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K; Ishikawa H; Suzuki H
    J Infect Chemother; 2021 Jun; 27(6):890-894. PubMed ID: 33727026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 rapid antigen test in comparison to RT-PCR targeting different genes: A real-life evaluation among unselected patients in a regional hospital of Italy.
    Treggiari D; Piubelli C; Caldrer S; Mistretta M; Ragusa A; Orza P; Pajola B; Piccoli D; Conti A; Lorenzi C; Serafini V; Boni M; Perandin F
    J Med Virol; 2022 Mar; 94(3):1190-1195. PubMed ID: 34617606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
    Pickering S; Batra R; Merrick B; Snell LB; Nebbia G; Douthwaite S; Reid F; Patel A; Kia Ik MT; Patel B; Charalampous T; Alcolea-Medina A; Lista MJ; Cliff PR; Cunningham E; Mullen J; Doores KJ; Edgeworth JD; Malim MH; Neil SJD; Galão RP
    Lancet Microbe; 2021 Sep; 2(9):e461-e471. PubMed ID: 34226893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.